DrugCite
Search

REMINYL

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Reminyl Adverse Events Reported to the FDA Over Time

How are Reminyl adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Reminyl, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Reminyl is flagged as the suspect drug causing the adverse event.

Most Common Reminyl Adverse Events Reported to the FDA

What are the most common Reminyl adverse events reported to the FDA?

Death
114 (2.47%)
Medication Error
100 (2.17%)
Nausea
92 (1.99%)
Vomiting
91 (1.97%)
Fall
90 (1.95%)
Confusional State
81 (1.75%)
Bradycardia
77 (1.67%)
Drug Interaction
67 (1.45%)
No Adverse Event
60 (1.3%)
Malaise
59 (1.28%)
Drug Dispensing Error
57 (1.23%)
Show More Show More
Syncope
52 (1.13%)
Agitation
49 (1.06%)
Somnolence
49 (1.06%)
Loss Of Consciousness
48 (1.04%)
Diarrhoea
47 (1.02%)
Dehydration
44 (.95%)
Weight Decreased
44 (.95%)
Dizziness
43 (.93%)
Overdose
42 (.91%)
Renal Failure
41 (.89%)
Asthenia
39 (.84%)
Accidental Overdose
38 (.82%)
Cerebrovascular Accident
36 (.78%)
Decreased Appetite
36 (.78%)
Pneumonia
34 (.74%)
Incorrect Dose Administered
33 (.71%)
Arrhythmia
32 (.69%)
General Physical Health Deteriorati...
32 (.69%)
Hypoglycaemia
32 (.69%)
Depressed Level Of Consciousness
31 (.67%)
Dyspnoea
28 (.61%)
Aggression
26 (.56%)
Hypertension
26 (.56%)
Myocardial Infarction
26 (.56%)
Abnormal Behaviour
25 (.54%)
Cardiac Arrest
25 (.54%)
Drug Administration Error
25 (.54%)
Drug Prescribing Error
25 (.54%)
Atrial Fibrillation
24 (.52%)
Cardiac Failure Congestive
24 (.52%)
Hypotension
24 (.52%)
Pneumonia Aspiration
24 (.52%)
Blood Pressure Increased
23 (.5%)
Convulsion
23 (.5%)
Coma
22 (.48%)
Sepsis
22 (.48%)
Tremor
22 (.48%)
Urinary Tract Infection
22 (.48%)
Inappropriate Schedule Of Drug Admi...
21 (.45%)
Restlessness
21 (.45%)
Condition Aggravated
20 (.43%)
Balance Disorder
19 (.41%)
Disorientation
19 (.41%)
Pulmonary Embolism
18 (.39%)
Wrong Drug Administered
18 (.39%)
Alanine Aminotransferase Increased
17 (.37%)
Psychotic Disorder
17 (.37%)
Abasia
16 (.35%)
Delirium
16 (.35%)
Gait Disturbance
16 (.35%)
Headache
16 (.35%)
Anxiety
15 (.32%)
Aspartate Aminotransferase Increase...
15 (.32%)
Pancreatitis
15 (.32%)
Transient Ischaemic Attack
15 (.32%)
Anaemia
14 (.3%)
Atrioventricular Block Complete
14 (.3%)
Cognitive Disorder
14 (.3%)
Hallucination
14 (.3%)
Renal Failure Acute
14 (.3%)
Aphasia
13 (.28%)
Blood Albumin Decreased
13 (.28%)
Electrocardiogram Qt Prolonged
13 (.28%)
Fatigue
13 (.28%)
Hyperhidrosis
13 (.28%)
Hyponatraemia
13 (.28%)
Pyrexia
13 (.28%)
Abdominal Pain
12 (.26%)
Anorexia
12 (.26%)
Blood Bilirubin Increased
12 (.26%)
Cardiac Failure
12 (.26%)
Gamma-glutamyltransferase Increased
12 (.26%)
Lethargy
12 (.26%)
Sudden Death
12 (.26%)
Vertigo
12 (.26%)
Asthma
11 (.24%)
Blood Creatinine Increased
11 (.24%)
Cytolytic Hepatitis
11 (.24%)
Delusion
11 (.24%)
Hepatitis
11 (.24%)
Liver Function Test Abnormal
11 (.24%)
Orthostatic Hypotension
11 (.24%)
Speech Disorder
11 (.24%)
Accidental Exposure
10 (.22%)
Blood Pressure Decreased
10 (.22%)
Cholestasis
10 (.22%)
Decubitus Ulcer
10 (.22%)
Dementia
10 (.22%)
Depression
10 (.22%)
Eructation
10 (.22%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Reminyl, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Reminyl is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Reminyl

What are the most common Reminyl adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Reminyl, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Reminyl is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Reminyl According to Those Reporting Adverse Events

Why are people taking Reminyl, according to those reporting adverse events to the FDA?

Dementia Alzheimers Type
453
Drug Use For Unknown Indication
378
Dementia
231
Product Used For Unknown Indication
27
Memory Impairment
16
Vascular Dementia
12
Show More Show More
Cognitive Disorder
12
Senile Dementia
8
Parkinsons Disease
4
Depression
4
Presenile Dementia
4
Amnesia
4
Aggression
3
Traumatic Brain Injury
2
Ill-defined Disorder
2
Abnormal Behaviour
2
Extrapyramidal Disorder
1
Accidental Exposure
1
Cerebral Arteriosclerosis
1
Psychotic Disorder
1
Head Injury
1
Pain
1
Mental Disorder
1
Unevaluable Event
1
Aphasia
1
Hallucination
1
Adverse Event
1

Reminyl Case Reports

What Reminyl safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Reminyl. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Reminyl.